Geneva Capital Management Llc
Source: SEC Form 13F · as of Mar 2026Geneva Capital Management Llc holds 6 biotech & pharma companies tracked by BioSniper, totaling $377.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
6
Total value held
$377.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Globus Medical Inc. (GMED)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GMEDGlobus Medical Inc. | 1,760,971 | $151.7M |
| RGENREPLIGEN CORP | 693,738 | $81.7M |
| TECHBIO-TECHNE Corp | 1,243,043 | $65.0M |
| VCELVericel Corp | 1,646,818 | $53.0M |
| IDXXIDEXX LABORATORIES INC /DE | 43,008 | $24.2M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 11,942 | $2.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.